Asia Pacific Ice Cream Market Size To Grow At 4.11% CAGR Till 2033

The Asia Pacific ice cream market size was exhibited at USD 42.85 billion in 2023 and is projected to hit around USD 64.10 billion by 2033, growing at a CAGR of 4.11% during the forecast period 2024 to 2033.

Download Free Sample Copy for Better Understanding@ https://www.novaoneadvisor.com/report/sample/8868

Asia Pacific Ice Cream Market Key Takeaways:

• Based on source, the dairy & water-segment led the market with the largest revenue share of 94.5% in 2023.
• The vegan segment is projected to grow at the fastest CAGR of 9.0% from 2024 to 2033.
• Based on flavor, the vanilla segment led the market with the largest revenue share of 31.6% in 2023.
• The fruit segment is projected to grow at the fastest CAGR of 5.5% from 2024 to 2033.
• Based on packaging, the ice cream bars segment led the market with the largest revenue share of 32.8% in 2023.
• The ice cream cones segment is projected to grow at the fastest CAGR of 5.3% from 2024 to 2033.
• Based on distribution channel, the hypermarkets & supermarkets segment led the market with the largest revenue share of 33.0% in 2023.
• The online channels segment is projected to grow at the fastest CAGR of 6.1% from 2024 to 2033.

The Asia-Pacific market is experiencing growth due to consumers having higher disposable incomes and a preference for purchasing high-quality ice cream products. This growth is fueled by the increasing demand for food items like ice cream and frozen desserts in the region, with disposable income being primarily allocated towards food purchases.

The rise in ice cream production is supported by the expanding dairy market in the Asia-Pacific region. The trend of health-conscious consumers seeking ice creams with functional and health benefits is further driving the demand for high-quality products made with ingredients like mung bean and other nutritious components.

The increasing popularity of premium ice creams in the region is anticipated to be a key driver for market growth. Manufacturers are introducing new ice cream innovations, like sugar-free plant-based varieties, to cater to consumer preferences, thereby fueling the market growth of the Asia Pacific ice cream industry in the forecast period. In March 2024, Eclipse Foods, the plant-based ice cream brand known for its commitment to replicating the creamy texture and rich flavors of traditional dairy, launched its latest innovation: Eclipse Bonbons. This exciting new line takes the brand's signature non-dairy ice cream to a whole new level of indulgence, offering a luxurious treat that rivals the most decadent chocolate-covered ice cream bonbons.

Major players in the Asia Pacific market are investing heavily in research and development to introduce new and innovative flavor varieties of ice creams. In April 2024, Havmor, a brand under LOTTE Wellfood Co. Ltd, launched a fresh lineup of ice cream flavors just in time for the upcoming summer heatwave. The range features a mix of traditional favorites and contemporary twists. From classics like Shahi Kesar and Rajwadi Kulfi to modern delights such as Blueberry Cheesecake, Cookie and Cream cones, and ice cream sandwiches. It also added seasonal treats like Jaljeera & Kalakhatta, Ratnagiri Hapus, and rose-flavored ice cream for a cool and revitalizing indulgence.

The increasing expenditure on ice creams in Asian countries such as India, Japan, and New Zealand is projected to support market growth. For instance, according to Japan’s Ministry of Internal Affairs and Communications (MIC), expenditure on ice cream among Japanese consumers witnessed a 135% growth between 2011 and 2020.

Asia Pacific is characterized by an increasing demand for high-end ice creams. The changing consumption habits of consumers and the vast diversity in the region have led to the demand for varied flavor combinations and innovative ice creams. The region has also witnessed the introduction of new brands to the market, which has led to positive competition in the industry. For instance, Chicecream is a premium ice cream brand in China that focuses on high-end and creative ice creams. Founded in 2018, Chicecream was the No. 1 brand in terms of sales in the ice product sector on Tmall in 2020 and 2021. It is also immensely popular at China's annual Double 11 and 618 shopping festivals.

Asia Pacific Ice Cream Market By Source Insights

Based on source, the dairy & water-segment led the market with the largest revenue share of 94.5% in 2023. Dairy-based ice creams have long been traditional favorites across Asia Pacific countries. They are known for their creamy texture, rich flavors, and indulgent experience, appealing to a wide range of consumers. The dairy-based segment also witnesses premiumization, with gourmet flavors, artisanal craftsmanship, and high-quality ingredients becoming increasingly popular. Consumers are willing to pay more for unique and premium dairy-based ice cream experiences.

Asia Pacific Ice Cream Market By Flavor Insights

Based on flavor, the vanilla segment led the market with the largest revenue share of 31.6% in 2023. Vanilla serves as a base flavor for many other ice cream variations and desserts. It complements a variety of ingredients and can be easily incorporated into different recipes, from sundaes and milkshakes to cakes and pies. This versatility enhances its appeal and usage in both homemade and commercial ice cream products. High-quality vanilla ice cream, made with real vanilla extract or vanilla beans, offers a rich and authentic flavor profile that distinguishes it from artificial alternatives. Consumers appreciate the use of natural ingredients and superior flavor, enhancing their preference for vanilla-flavored ice cream.

Asia Pacific Ice Cream Market By Packaging Insights

Based on packaging, the ice cream bars segment led the market with the largest revenue share of 32.8% in 2023. Bars packaging offers convenience and portability, making it an ideal choice for on-the-go consumption. Consumers can easily enjoy ice cream bars without the need for bowls or utensils, making them suitable for outdoor activities, travel, and quick indulgences. Ice cream bars come in a variety of flavors and formats, catering to diverse consumer preferences. From classic flavors like chocolate and vanilla to innovative combinations like fruit swirls, nuts, caramel, and cookie coatings, there's a wide range of options to choose from, enhancing consumer choice and satisfaction.

Asia Pacific Ice Cream Market By Distribution Channel Insights

Based on distribution channel, the hypermarkets & supermarkets segment led the market with the largest revenue share of 33.0% in 2023. Brands have been diversifying their product offerings in supermarkets and hypermarkets by introducing a wide array of items like sundaes, fudge, bars, popsicles, and fusion products combining two or more flavors. This expansion is driven by the rising consumer interest in exploring new flavors. The increasing demand for sundaes, coupled with the availability of a broad selection of products in supermarkets and hypermarkets, is anticipated to boost sales through these retail channels.

Country Insights

Japan Ice Cream Market Trends

Japan dominated the Asia Pacific ice cream market with the revenue share of 21.8% in 2023. According to the Japan Ice Cream Association, Japanese consumers are flexible and respond well to new products in the market. As a result, the ice cream market in the country is characterized by unique and seasonal flavors, combined with traditional Japanese ingredients and flavors. For instance, the ice cream brand H?agen-Dazs offers innovative flavors such as Hojicha Latte, which is a typical Japanese tea-based flavor loved by people of all ages, the Hanamochi Kinako Kuromitsu flavor, which perfectly encapsulates Japanese cuisine and contains mochi pieces (rice cakes), and the Hanamochi Zunda ice cream, which combines the deliciousness of zunda mochi and lightly salted edamame.

Japanese consumers appreciate traditional flavors like matcha, black sesame, and cherry blossom, alongside more adventurous options such as squid ink and wasabi. Manufacturers are constantly introducing new and unique flavors to cater to diverse preferences. In March 2024, Eclipse Foods introduced its plant-based ice cream in Japan under the brand name "eclipseco." This Japanese product line features enticing flavors like Cookie Butter Crumble, Classic Chocolate, and Mango Passion Fruit, now accessible at Family Mart stores across Tokyo. Kaori Onguchi, the company's country manager for Japan, hailed this move as a pivotal milestone, emphasizing that it marks merely the initial step in their journey.

China Ice Cream Market Trends

The ice cream market in China is mainly driven by changing dietary habits, rising disposable incomes, and a growing middle-class population. According to the State Council Information Office of the People’s Republic of China, the per capita disposable income in China increased by 5% between 2021 and 2022 and stood at about USD 5,487 in 2022. Moreover, according to a report published on the China-US Focus platform, China’s middle-income population accounted for around 76% of urban Chinese households and 45% of the entire Chinese population in 2022. This growth of the middle-income population group and a subsequent rise in purchasing power will provide ample opportunities for the growth of premium and artisanal ice cream brands in China.

Asia Pacific Ice Cream Market Recent Developments

• In January 2024, Singapore's OATSIDE has recently broadened its range by introducing a new line of ice cream, leveraging its distinctive oat milk as the primary component. This fresh ice cream collection is currently offered in three flavors: chocolate, peanut butter cookie dough, and coffee with mini chocolate chips
• In March 2023, Chinese dairy giant Mengniu has taken a significant step in expanding its global reach with the completion of the most extensive smart ice cream factory in Southeast Asia (ASEAN). This new facility, operated by its subsidiary brand Aice Group, marks a historic moment for the Philippines - it is the country's first intelligent ice cream factory
• In March 2023, Healthy ice cream brand NOTO introduced three new Indian-flavored gelatos that are denser, richer, and creamier, containing half the fat and sugar. Each of these flavors has a significant historical connection with the Indian palate, resonating deeply with consumers

Some of the prominent players in the Asia Pacific ice cream market include:

• Nestle SA
• General Mills Inc.
• Appolo Ice Cream Co Ltd;
• Unilever PLC
• Yili Group
• CAMPINA ICE CREAM INDUSTRY Tbk.
• Diamond Food Indonesia
• Dairy Bell Ice Cream
• PT. United Family Food
• Froneri International Limited

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to com

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the Asia Pacific ice cream market

Source

• Dairy & Water-based
• Vegan

Flavor

• Vanilla
• Chocolate
• Fruit
• Cookie & Cream
• Nut
• Others

Packaging

• Cartons
• Tubs
• Cups
• Cones
• Bars

Distribution Channel

• Hypermarkets & Supermarkets
• Convenience Stores
• Ice Cream Parlor
• Online
• Others

Country

• Hong Kong
• Taiwan
• South Korea
• Thailand
• Singapore
• Indonesia
• Australia
• New Zealand
• Japan

Quick Buy This Premium Report From Here: https://www.novaoneadvisor.com/report/checkout/8868 ?

Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com

You can place an order or ask any questions, please feel free to [email protected] | +1 9197 992 333

About US

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Connect with Us

Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

IND Address: 2nd Floor,Shreeleela Plaza, Baner Road, Pune, Maharashtra - 411045

Call: USA - +1 650 460 3308 | IND - +91 87933 22019

[email protected]

Web: https://www.novaoneadvisor.com/

Nova One Advisor Group Offer Other Reports:

Cell Therapy Market Size and Forecast:?The global?cell therapy market size was exhibited at USD 4.85 billion in 2023 and is projected to hit around USD 37.42 billion by 2033, growing at a CAGR of 22.67% during the forecast period 2024 to 2033.

Gene Therapy Market Size and Forecast?:?The global?gene therapy market size was exhibited at USD 8.75 billion in 2023 and is projected to hit around USD 52.40 billion by 2033, growing at a CAGR of 19.6% during the forecast period 2024 to 2033.

Cell And Gene Therapy Manufacturing Market Size and Forecast:?The global?cell and gene therapy manufacturing market size was estimated at USD 9.95 billion in 2023 and is projected to hit around USD 106.03 billion by 2033, growing at a CAGR of 26.7% during the forecast period from 2024 to 2033.

Cell and Gene Therapy Market?Size and Forecast:?The global?cell and gene therapy market size was estimated at USD 18.13 billion in 2023 and is projected to hit around USD 97.33 billion by 2033, growing at a CAGR of 18.3% during the forecast period from 2024 to 2033.

U.S. Cell Therapy Market Size and Forecast:?The?U.S. cell therapy market size was estimated at USD 2.88 billion in 2023 and is projected to hit around USD 19.67 billion by 2033, growing at a CAGR of 21.18% during the forecast period from 2024 to 2033.

U.S. Gene Therapy Market Size and Forecast:?The?U.S. gene therapy market size ?was estimated at USD 3.19 billion in 2023 and is projected to hit around USD 18.50 billion by 2033, growing at a CAGR of 19.22% during the forecast period from 2024 to 2033.

T-cell Therapy Market Size and Forecast:?The global?T-Cell therapy market size ?was exhibited at USD 3.85 billion in 2023 and is projected to hit around USD 79.62 billion by 2033, growing at a CAGR of 35.38% during the forecast period 2024 to 2033.

Cancer Immunotherapy Market?Size and Forecast:?The global?cancer immunotherapy market? size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.

Immunotherapy Drugs Market?:?The global?immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.

Clinical Trials Market Size and Forecast:?The?global clinical trials market size was estimated at USD 81.90 billion in 2023 and is projected to hit around USD 153.59 billion by 2033, growing at a CAGR of 6.49% during the forecast period from 2024 to 2033.

Biologics Market Size and Forecast: The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.

Biotechnology Market Size and Forecast:? The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.

Oncology? Market Size and Forecast: The?global oncology market size was estimated at USD 222.36 billion in 2023 and is projected to hit around USD 521.60 billion by 2033, growing at a CAGR of 8.9% during the forecast period from 2024 to 2033.

Cell And Gene Therapy Clinical Trials?Market Size and Forecast: The global cell and gene therapy clinical trials market size reached USD 11.62 billion in 2023 and is projected to hit around USD 47.40 billion by 2033, expanding at a CAGR of 15.09% during the forecast period from 2024 to 2033.

U.S. Clinical Trials Market Size and Forecast:?The?U.S. clinical trials market size was valued at USD 25.81 billion in 2023 and is projected to surpass around USD 41.57 billion by 2033, registering a CAGR of 4.88% over the forecast period of 2024 to 2033.

Active Pharmaceutical Ingredient CDMO Market:?The global active pharmaceutical ingredient CDMO market size was valued at USD 119.80 billion in 2023 and is anticipated to reach around USD 249.22 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.

U.S. Pharmaceutical Market?:?The U.S. pharmaceutical market size was valued at USD 602.19 billion in 2023 and is projected to surpass around USD 1,093.79 billion by 2033, registering a CAGR of 6.15% over the forecast period of 2024 to 2033.

Viral Vector And Plasmid DNA Manufacturing Market:?The global viral vector and plasmid DNA manufacturing market size ?was valued at USD 6.19 billion in 2023 and is anticipated to reach around USD 39.30 billion by 2033, growing at a CAGR of 20.3% from 2024 to 2033.

U.S. Viral Vector And Plasmid DNA Manufacturing Market ;?The U.S. viral vector and plasmid DNA manufacturing market size was valued at USD 2.45 billion in 2023 and is expected to be worth around USD 15.30 billion by 2033, with a registered CAGR of 20.1% during forecast period 2024 to 2033.

Compounding Pharmacies Market :?The global compounding pharmacies market size ?was valued at USD 16.19 billion in 2023 and is anticipated to reach around USD 30.97 billion by 2033, growing at a CAGR of 6.7% from 2024 to 2033.

U.S. Compounding Pharmacies Market?:?The U.S. compounding pharmacies market size ?is projected to be worth around USD 10.76 billion by 2033 from USD 6.31 billion in 2024, at a CAGR of 6.1% from 2024 to 2033.

Antibiotics Market: The?global antibiotics market size ?was valued at USD 51.19 billion in 2023 and is projected to surpass around USD 85.80 billion by 2033, registering a CAGR of 5.3% over the forecast period of 2024 to 2033.

Biologics Market :?The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.

Biotechnology Market:?The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.

Next Generation Sequencing Market?:?The?global next generation sequencing market size was estimated at USD 9.19 billion in 2023 and is projected to hit around USD 66.04 billion by 2033, growing at a CAGR of 21.8% during the forecast period from 2024 to 2033.

Genome Editing Market ;?The?global genome editing market size ?was valued at USD 8.45 billion in 2023 and is anticipated to reach around USD 40.48 billion by 2033, growing at a CAGR of 16.96% from 2024 to 2033.

U.S. Genome Editing Market:?The?U.S. genome editing market size was estimated at USD 3.55 billion in 2023 and is projected to hit around USD 16.49 billion by 2033, growing at a CAGR of 16.6% during the forecast period from 2024 to 2033.

U.S. Gene Synthesis Market?:?The?U.S. Gene Synthesis market size was valued at USD 700.90 million in 2023 and is projected to surpass around USD 3,118.73 million by 2033, registering a CAGR of 16.1% over the forecast period of 2024 to 2033.

Biopharmaceutical Market :?The global?Biopharmaceutical market size accounted for USD 327.46 billion in 2022 and is estimated to achieve a market size of USD 1,101.77 billion by 2032 growing at a CAGR of 12.9% from 2023 to 2032.

Immunotherapy Drugs Market?:?The?global immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.

Cancer Immunotherapy Market:?The global cancer immunotherapy market size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.

U.S. Plasmid DNA Manufacturing Market?:?The U.S. plasmid DNA manufacturing market size ?was valued at USD 711.90 million in 2023 and is projected to surpass around USD 4,885.15 million by 2033, registering a CAGR of 21.24% over the forecast period of 2024 to 2033.

U.S. Precision Medicine Market?:?The?U.S. precision medicine market size was valued at USD 24.95 billion in 2023 and is projected to reach around USD 76.12 billion by 2033, registering a CAGR of 11.80% from 2024 to 2033.